Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Biopharma Week in Review - September 9, 2024
Thematic (Sector/Industry)
65 Views
10 Sep 2024 22:23
Issuer-paid
Last week, PCVX had pneumococcal vaccine data that could seriously challenge PFE’s market leading Prevnar 20. TVTX celebrated full FDA approval of its IgAN drug, just in time for new KDIGO guidelines.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Loading
Trending Insights
More »
ESR Group (1821 HK): Precondition Satisfied
FXI Rebalance Preview: Pop Mart (9992 HK) Pops Up Again
CATL (3750 HK): Powered by the PetroDollar. HK Offer Overview and Valuations.
A Practical Guide to Stub Arb Trade in the Korean Stock Market
US-Listed China Plays: Thoughts On Dissention
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Insight Stream
Loading...
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x